Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its price objective lifted by Ascendiant Capital Markets from $1.50 to $2.00 in a research report released on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other research firms have also issued reports on OTLK. HC Wainwright raised shares […]
Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been assigned a consensus rating of “Hold” from the seven research firms that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average […]
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) has been given an average recommendation of “Hold” by the seven research firms that are currently covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 […]
Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have earned an average rating of “Hold” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1-year target price […]